GNRHR and hyperplasia: The same team identified GnRHR expression in 4/15 (26.7%) adrenal adenomas or hyperplasia leading to primary aldosteronism, concordant with the previous work of Saner-Amigh et al., showing GnRHR expression in 11/28 (39.3%) adrenal producing adenomas (4).